Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 8 | 2023 | 1202 | 2.520 |
Why?
|
| Ileostomy | 2 | 2018 | 46 | 1.210 |
Why?
|
| Crohn Disease | 3 | 2019 | 351 | 1.070 |
Why?
|
| Patient Readmission | 2 | 2018 | 548 | 0.900 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 481 | 0.900 |
Why?
|
| Laparoscopy | 3 | 2023 | 1225 | 0.840 |
Why?
|
| Narcotics | 1 | 2022 | 123 | 0.800 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 2594 | 0.760 |
Why?
|
| Pelvis | 2 | 2023 | 362 | 0.760 |
Why?
|
| Simulation Training | 1 | 2021 | 149 | 0.680 |
Why?
|
| Colectomy | 2 | 2022 | 288 | 0.680 |
Why?
|
| Neoadjuvant Therapy | 4 | 2020 | 4975 | 0.660 |
Why?
|
| Biological Factors | 1 | 2018 | 45 | 0.650 |
Why?
|
| Colorectal Surgery | 1 | 2018 | 32 | 0.650 |
Why?
|
| General Surgery | 2 | 2019 | 326 | 0.620 |
Why?
|
| Robotics | 1 | 2021 | 359 | 0.600 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 394 | 0.590 |
Why?
|
| Ileum | 2 | 2019 | 165 | 0.590 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 250 | 0.570 |
Why?
|
| Peritoneal Diseases | 1 | 2016 | 29 | 0.570 |
Why?
|
| Hirschsprung Disease | 1 | 2016 | 46 | 0.570 |
Why?
|
| Students, Medical | 1 | 2021 | 399 | 0.550 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2018 | 565 | 0.520 |
Why?
|
| Deoxycytidine | 1 | 2021 | 1353 | 0.520 |
Why?
|
| Abscess | 1 | 2016 | 177 | 0.510 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2021 | 3890 | 0.500 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 225 | 0.490 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 1390 | 0.450 |
Why?
|
| Myxoma | 1 | 2013 | 63 | 0.450 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 622 | 0.440 |
Why?
|
| Preoperative Care | 2 | 2018 | 1529 | 0.440 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 945 | 0.430 |
Why?
|
| Postoperative Complications | 4 | 2023 | 5542 | 0.420 |
Why?
|
| Pelvic Neoplasms | 1 | 2013 | 189 | 0.410 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 748 | 0.410 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 918 | 0.380 |
Why?
|
| Telemedicine | 1 | 2017 | 471 | 0.380 |
Why?
|
| Dissection | 2 | 2023 | 156 | 0.370 |
Why?
|
| Internship and Residency | 2 | 2019 | 1375 | 0.360 |
Why?
|
| Medical Oncology | 1 | 2018 | 1423 | 0.350 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 3578 | 0.330 |
Why?
|
| Postoperative Period | 2 | 2022 | 665 | 0.320 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 2403 | 0.310 |
Why?
|
| Circulating Tumor DNA | 2 | 2021 | 235 | 0.310 |
Why?
|
| Florida | 2 | 2017 | 113 | 0.300 |
Why?
|
| Fluorouracil | 2 | 2021 | 1944 | 0.250 |
Why?
|
| Humans | 25 | 2023 | 261506 | 0.230 |
Why?
|
| Retrospective Studies | 6 | 2023 | 37905 | 0.220 |
Why?
|
| Male | 13 | 2023 | 123000 | 0.200 |
Why?
|
| Treatment Outcome | 6 | 2021 | 32848 | 0.200 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 13658 | 0.190 |
Why?
|
| Morphine | 1 | 2022 | 308 | 0.180 |
Why?
|
| Capecitabine | 1 | 2021 | 388 | 0.180 |
Why?
|
| Career Choice | 1 | 2021 | 232 | 0.170 |
Why?
|
| Standard of Care | 1 | 2020 | 243 | 0.170 |
Why?
|
| Aged | 8 | 2018 | 70117 | 0.170 |
Why?
|
| Female | 14 | 2021 | 141928 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2018 | 275 | 0.170 |
Why?
|
| Community Networks | 1 | 2018 | 45 | 0.160 |
Why?
|
| Rectum | 1 | 2020 | 467 | 0.160 |
Why?
|
| Middle Aged | 8 | 2018 | 86204 | 0.160 |
Why?
|
| Operative Time | 1 | 2018 | 217 | 0.160 |
Why?
|
| Hernia | 1 | 2017 | 46 | 0.150 |
Why?
|
| Disease-Free Survival | 2 | 2020 | 10001 | 0.150 |
Why?
|
| Preoperative Period | 1 | 2018 | 344 | 0.150 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8865 | 0.150 |
Why?
|
| Cadaver | 1 | 2017 | 237 | 0.150 |
Why?
|
| Perineum | 1 | 2017 | 107 | 0.150 |
Why?
|
| Schools, Medical | 1 | 2017 | 132 | 0.140 |
Why?
|
| Dehydration | 1 | 2017 | 87 | 0.140 |
Why?
|
| Leadership | 1 | 2019 | 254 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 309 | 0.140 |
Why?
|
| Mesentery | 1 | 2016 | 72 | 0.140 |
Why?
|
| Faculty, Medical | 1 | 2019 | 289 | 0.140 |
Why?
|
| Telephone | 1 | 2017 | 163 | 0.140 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 610 | 0.140 |
Why?
|
| Age of Onset | 1 | 2018 | 827 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 1529 | 0.140 |
Why?
|
| United States | 4 | 2022 | 15433 | 0.140 |
Why?
|
| Adult | 6 | 2018 | 77950 | 0.130 |
Why?
|
| Surgical Mesh | 1 | 2017 | 209 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2018 | 6869 | 0.130 |
Why?
|
| Herniorrhaphy | 1 | 2017 | 169 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 390 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2017 | 228 | 0.130 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 202 | 0.130 |
Why?
|
| Fibrosis | 1 | 2018 | 793 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2019 | 1234 | 0.120 |
Why?
|
| Intussusception | 1 | 2014 | 52 | 0.120 |
Why?
|
| Counseling | 1 | 2017 | 381 | 0.120 |
Why?
|
| Colonic Diseases | 1 | 2014 | 71 | 0.120 |
Why?
|
| Intestines | 1 | 2018 | 686 | 0.120 |
Why?
|
| Sacrococcygeal Region | 1 | 2013 | 37 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 363 | 0.120 |
Why?
|
| Pain | 1 | 2022 | 1658 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2021 | 1270 | 0.110 |
Why?
|
| Prognosis | 3 | 2021 | 21713 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 1121 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 600 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2018 | 1335 | 0.100 |
Why?
|
| Young Adult | 3 | 2018 | 21445 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 915 | 0.100 |
Why?
|
| Logistic Models | 1 | 2018 | 3441 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2017 | 2803 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2017 | 927 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2018 | 2203 | 0.090 |
Why?
|
| Length of Stay | 1 | 2017 | 1900 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 4892 | 0.090 |
Why?
|
| Age Factors | 1 | 2018 | 5377 | 0.080 |
Why?
|
| Adolescent | 2 | 2018 | 31252 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2018 | 9180 | 0.070 |
Why?
|
| Carcinoma | 1 | 2017 | 2578 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 5687 | 0.070 |
Why?
|
| Survival Rate | 1 | 2018 | 12221 | 0.060 |
Why?
|
| Catastrophization | 1 | 2021 | 11 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 15862 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 10331 | 0.050 |
Why?
|
| Risk Factors | 1 | 2018 | 17523 | 0.050 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 2 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Liquid Biopsy | 1 | 2020 | 158 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2020 | 211 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2019 | 29 | 0.040 |
Why?
|
| Sexism | 1 | 2019 | 51 | 0.040 |
Why?
|
| Gender Identity | 1 | 2019 | 75 | 0.040 |
Why?
|
| Inflammation | 2 | 2019 | 2522 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 29902 | 0.040 |
Why?
|
| Elasticity | 1 | 2018 | 156 | 0.040 |
Why?
|
| Tyrosine | 1 | 2019 | 498 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 953 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2018 | 204 | 0.040 |
Why?
|
| Autografts | 1 | 2017 | 165 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2019 | 479 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 777 | 0.040 |
Why?
|
| Cattle | 1 | 2018 | 783 | 0.040 |
Why?
|
| Ascites | 1 | 2017 | 198 | 0.040 |
Why?
|
| Colon | 1 | 2020 | 670 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2019 | 677 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2020 | 1656 | 0.030 |
Why?
|
| Malnutrition | 1 | 2017 | 218 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1541 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 2139 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2017 | 739 | 0.030 |
Why?
|
| Uterus | 1 | 2017 | 678 | 0.030 |
Why?
|
| Pain Management | 1 | 2017 | 668 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2019 | 4804 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 3570 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 5047 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 6682 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 6942 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 12873 | 0.020 |
Why?
|
| Palliative Care | 1 | 2017 | 2037 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 7222 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 14889 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 7702 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 7551 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 59536 | 0.010 |
Why?
|